vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $34.3M, roughly 1.2× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -17.2%, a 15.5% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -3.2%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-2.4M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

CLFD vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.2× larger
STIM
$41.8M
$34.3M
CLFD
Growing faster (revenue YoY)
STIM
STIM
+88.9% gap
STIM
85.7%
-3.2%
CLFD
Higher net margin
CLFD
CLFD
15.5% more per $
CLFD
-1.8%
-17.2%
STIM
More free cash flow
STIM
STIM
$3.1M more FCF
STIM
$692.0K
$-2.4M
CLFD
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
STIM
STIM
Revenue
$34.3M
$41.8M
Net Profit
$-614.0K
$-7.2M
Gross Margin
33.2%
52.0%
Operating Margin
-5.3%
-12.1%
Net Margin
-1.8%
-17.2%
Revenue YoY
-3.2%
85.7%
Net Profit YoY
67.8%
43.2%
EPS (diluted)
$-0.04
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
STIM
STIM
Q4 25
$34.3M
$41.8M
Q3 25
$23.4M
$37.3M
Q2 25
$49.9M
$38.1M
Q1 25
$47.2M
$32.0M
Q4 24
$29.7M
$22.5M
Q3 24
$5.6M
$18.5M
Q2 24
$48.8M
$16.4M
Q1 24
$36.9M
$17.4M
Net Profit
CLFD
CLFD
STIM
STIM
Q4 25
$-614.0K
$-7.2M
Q3 25
$-9.1M
$-9.0M
Q2 25
$1.6M
$-10.1M
Q1 25
$1.3M
$-12.7M
Q4 24
$-1.9M
$-12.7M
Q3 24
$-13.3M
Q2 24
$-447.0K
$-9.8M
Q1 24
$-5.9M
$-7.9M
Gross Margin
CLFD
CLFD
STIM
STIM
Q4 25
33.2%
52.0%
Q3 25
53.2%
45.9%
Q2 25
30.5%
46.6%
Q1 25
30.1%
49.2%
Q4 24
29.2%
66.2%
Q3 24
75.6%
Q2 24
21.9%
74.0%
Q1 24
7.7%
75.1%
Operating Margin
CLFD
CLFD
STIM
STIM
Q4 25
-5.3%
-12.1%
Q3 25
10.3%
-19.6%
Q2 25
3.0%
-21.1%
Q1 25
0.6%
-34.4%
Q4 24
-6.9%
-51.0%
Q3 24
-41.7%
Q2 24
-4.7%
-51.7%
Q1 24
-26.4%
-39.4%
Net Margin
CLFD
CLFD
STIM
STIM
Q4 25
-1.8%
-17.2%
Q3 25
-38.8%
-24.3%
Q2 25
3.2%
-26.6%
Q1 25
2.8%
-39.6%
Q4 24
-6.4%
-56.4%
Q3 24
-72.0%
Q2 24
-0.9%
-59.8%
Q1 24
-16.0%
-45.2%
EPS (diluted)
CLFD
CLFD
STIM
STIM
Q4 25
$-0.04
$-0.10
Q3 25
$-0.65
$-0.13
Q2 25
$0.11
$-0.15
Q1 25
$0.09
$-0.21
Q4 24
$-0.13
$-0.34
Q3 24
$-0.44
Q2 24
$-0.04
$-0.33
Q1 24
$-0.40
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$96.4M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$249.7M
$22.4M
Total Assets
$268.1M
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
STIM
STIM
Q4 25
$96.4M
$28.1M
Q3 25
$106.0M
$28.0M
Q2 25
$117.2M
$11.0M
Q1 25
$112.0M
$20.2M
Q4 24
$113.0M
$18.5M
Q3 24
$129.0M
$20.9M
Q2 24
$123.8M
$42.6M
Q1 24
$142.9M
$47.7M
Total Debt
CLFD
CLFD
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$2.2M
$46.0M
Q2 24
$2.1M
$59.8M
Q1 24
$59.4M
Stockholders' Equity
CLFD
CLFD
STIM
STIM
Q4 25
$249.7M
$22.4M
Q3 25
$256.2M
$27.4M
Q2 25
$264.5M
$27.1M
Q1 25
$265.9M
$35.5M
Q4 24
$267.4M
$27.7M
Q3 24
$275.8M
$9.4M
Q2 24
$274.6M
$19.4M
Q1 24
$279.2M
$27.7M
Total Assets
CLFD
CLFD
STIM
STIM
Q4 25
$268.1M
$141.6M
Q3 25
$306.2M
$145.5M
Q2 25
$314.7M
$134.7M
Q1 25
$310.9M
$142.0M
Q4 24
$303.2M
$140.9M
Q3 24
$315.3M
Q2 24
$318.1M
$96.8M
Q1 24
$315.4M
$103.8M
Debt / Equity
CLFD
CLFD
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
0.01×
4.90×
Q2 24
0.01×
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
STIM
STIM
Operating Cash FlowLast quarter
$-1.4M
$908.0K
Free Cash FlowOCF − Capex
$-2.4M
$692.0K
FCF MarginFCF / Revenue
-7.1%
1.7%
Capex IntensityCapex / Revenue
2.9%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
STIM
STIM
Q4 25
$-1.4M
$908.0K
Q3 25
$-785.0K
Q2 25
$7.9M
$-3.5M
Q1 25
$3.0M
$-17.0M
Q4 24
$7.2M
$-8.6M
Q3 24
$22.2M
$-5.4M
Q2 24
$4.0M
$-5.0M
Q1 24
$-5.7M
$-12.0M
Free Cash Flow
CLFD
CLFD
STIM
STIM
Q4 25
$-2.4M
$692.0K
Q3 25
$-899.0K
Q2 25
$7.5M
$-3.8M
Q1 25
$654.0K
$-17.2M
Q4 24
$5.1M
$-8.7M
Q3 24
$18.2M
$-5.8M
Q2 24
$2.8M
$-5.6M
Q1 24
$-7.7M
$-12.4M
FCF Margin
CLFD
CLFD
STIM
STIM
Q4 25
-7.1%
1.7%
Q3 25
-2.4%
Q2 25
15.1%
-9.9%
Q1 25
1.4%
-53.8%
Q4 24
17.1%
-38.6%
Q3 24
323.0%
-31.3%
Q2 24
5.8%
-34.0%
Q1 24
-20.8%
-71.1%
Capex Intensity
CLFD
CLFD
STIM
STIM
Q4 25
2.9%
0.5%
Q3 25
2.0%
0.3%
Q2 25
0.8%
0.7%
Q1 25
5.1%
0.7%
Q4 24
7.0%
0.4%
Q3 24
71.4%
2.1%
Q2 24
2.5%
3.7%
Q1 24
5.3%
2.2%
Cash Conversion
CLFD
CLFD
STIM
STIM
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons